ARIAD Pharmaceuticals Competitors and Similar CompaniesClear all
ARIAD Pharmaceuticals's competitors and similar companies include GlycoMimetics, Processa Pharmaceuticals, ViroStatics and Providence Therapeutics.
 ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Processa Pharmaceuticals Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need. |  Providence Therapeutics Providence Therapeutics is a company that develops personalized mRNA-based cancer vaccines. | ||
Founding Date | Founding Date 1991 | Founding Date 2003 | Founding Date 2017 | Founding Date 2005 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Rockville, US HQ | Locations Hanover, US HQ | Locations Sassari, IT HQ Tramariglio, IT | Locations Calgary, CA HQ |
Employees | Employees 1381% increase | Employees 5025% increase | Employees 1033% decrease | Employees 8 | Employees 5610% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 31.6 m | Valuation ($) 4.4 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $118.8m (FY, 2015) | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($231.2m) (FY, 2015) | Net income ($153.9m) (FY, 2025) | Net income ($13.6m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 101.8m | Total funding raised N/A | Total funding raised $ 53k | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View companyProcessa Pharmaceuticals
HQ
Hanover, US
Employees
10↓ 33% decrease
Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need.
View companyProvidence Therapeutics
HQ
Calgary, CA
Employees
56↑ 10% increase
Providence Therapeutics is a company that develops personalized mRNA-based cancer vaccines.
View company